These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3385720)

  • 1. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
    Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720
    [No Abstract]   [Full Text] [Related]  

  • 2. 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
    Shutske GM; Pierrat FA; Kapples KJ; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1989 Aug; 32(8):1805-13. PubMed ID: 2754707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrine in Alzheimer's disease.
    Levy R
    Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B; Stoof JC
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA queries Alzheimer's trial results.
    Marx JL
    Science; 1988 Feb; 239(4843):969. PubMed ID: 3278380
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic trials using tacrine and other cholinesterase inhibitors.
    Gamzu ER; Thal LJ; Davis KL
    Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.
    Patocka J; Jun D; Kuca K
    Curr Drug Metab; 2008 May; 9(4):332-5. PubMed ID: 18473751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine and lecithin in Alzheimer's disease.
    BMJ; 1990 Apr; 300(6729):939-40. PubMed ID: 2337722
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies.
    Summers WK; Tachiki KH; Kling A
    Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THA and Alzheimer's disease.
    Hayward L; Brodaty H
    Aust N Z J Psychiatry; 1987 Dec; 21(4):618-9. PubMed ID: 3449055
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrine in relation to amino acid transmitters in Alzheimer's disease.
    Bowen DM; Steele JE; Lowe SL; Palmer AM
    Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197
    [No Abstract]   [Full Text] [Related]  

  • 12. Tetrahydroaminoacridine and Alzheimer's disease.
    Levy R
    Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrine in Alzheimer's disease.
    Davies B; Andrewes D; Stargatt R; Ames D; Tuckwell V; Davis S
    Lancet; 1989 Jul; 2(8655):163-4. PubMed ID: 2567933
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic treatment in Alzheimer's disease: encouraging results.
    Lancet; 1987 Jan; 1(8525):139-41. PubMed ID: 2879974
    [No Abstract]   [Full Text] [Related]  

  • 15. Tetrahydroaminoacridine in Alzheimer's disease.
    Walsh AC
    BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of THA for Alzheimer's disease.
    Brodaty H
    Med J Aust; 1990 Jun; 152(11):614. PubMed ID: 2348794
    [No Abstract]   [Full Text] [Related]  

  • 17. Tetrahydroaminoacridine (THA) in Alzheimer's disease.
    Byrne J; Arie T
    BMJ; 1989 Apr; 298(6677):845-6. PubMed ID: 2497817
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrahydroaminoacridine and Alzheimer's disease.
    Lancet; 1987 Feb; 1(8530):444-5. PubMed ID: 2880235
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type.
    N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydroaminoacridine and lecithin for Alzheimer's disease.
    N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.